Navigation Links
Align Technology Executive to Present at Upcoming Financial Conferences

SANTA CLARA, Calif., Sept. 4 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN), the inventor of Invisalign(R), a proprietary method of straightening teeth without wires and brackets, announced today that Thomas M. Prescott, President and Chief Executive Officer of Align Technology, is scheduled to speak at two upcoming financial conferences in New York. All presentations, as noted below, will be web cast live via the Internet on Align's web site at An archived replay will remain on the web site for one month. Details follow:

Conference: Bear Stearns 20th Annual Healthcare Conference

Date: Tuesday, September 11, 2007

Presentation: 11:00 to 11:25 a.m. Eastern Time

Breakout: 11:30 to 11:55 a.m. Eastern Time

Conference: UBS Global Life Sciences Conference

Date: Tuesday, September 25, 2007

Presentation: 11:00 to 11:25 a.m. Eastern Time

Breakout: 11:30 to 11:55 a.m. Eastern Time

About Align Technology, Inc.

Align Technology designs, manufactures and markets Invisalign, a proprietary method for treating malocclusion, or the misalignment of teeth. Invisalign corrects malocclusion using a series of clear, nearly invisible, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, Invisalign significantly reduces the aesthetic and other limitations associated with braces. Invisalign is appropriate for treating adults and older teens. Align Technology was founded in March 1997 and received FDA clearance to market Invisalign in 1998.

To learn more about Invisalign or to find a certified Invisalign doctor in your area, please visit or call 1-800-INVISIBLE.

Investor Relations Contact Press Contact

Shirley Stacy Shannon Mangum Henderson

Align Technology, Inc. Ethos Communication, Inc.

(408) 470-1150 (678) 540-9222

SOURCE Align Technology, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. A better test than cytology for Urinary Malignancy
2. Blood test developed for malignant hyperthermia
3. Malignant Mesothelioma – A New Genetic Revelatio
4. Malignant Mesothelioma – A New Genetic Revelation
5. Malignant virus in polio vaccine combined to Cancer
6. Indian Researcher Discovers Reason For Malignancy of Skin Cancer
7. Experimental Therapy Effective Against Malignant Melanoma in Horses
8. Seattle, a hub for malignant melanoma? Time To Get Sunwise!
9. Protein Involved In Embryo Formation Found In Malignant Cells
10. When Her Lot is maligned by HER-2, Staying Abreast is Imperative
11. Novel Suicide Gene Therapy Used to Treat Malignant Brain Tumors
Post Your Comments:
(Date:11/30/2015)... DC (PRWEB) , ... November ... ... Inc. (AIS) is pleased to announce the speakers for “Value-Based Payer-Provider Partnerships: ... lessons learned from three innovative value-based care arrangements: Essentia Health and UCare, ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... around Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue repair in the ... Matrix is a long-term resorbable surgical mesh intended to support and reinforce soft ...
(Date:11/30/2015)... Puerto Rico (PRWEB) , ... November 30, 2015 , ... ... active part of the San Juan Beauty Show held on November 8th and 9th ... was attended by media personalities, hair artists, renowned beauticians and top of the line ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... are pleased to announce their strategic partnership at the Radiological Society of ... Service, Inc., and Winscribe, global providers of cutting-edge dictation and speech-enabled documentation ...
(Date:11/30/2015)... ... 30, 2015 , ... World Patent Marketing , a ... household invention that provides an economical and easy way of gaining customized curtains. ... at 2.6%," says Scott Cooper, CEO and Creative Director of World Patent Marketing. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... Nov. 30, 2015   VolitionRx Limited (NYSE MKT: ... tests for a broad range of cancer types and other ... Micro Conference, which will be held December 1 - 3 in ... VolitionRx will be David Kratochvil , Chief Financial Officer ... Investor Relations. ® blood-based tests for colorectal ...
(Date:11/30/2015)... , November 30, 2015 PFE ... at up to 10 G protein-coupled receptor (GPCR) targets ... to research and develop potential new medicines directed at ... multiple therapeutic areas. --> Heptares Therapeutics ("Heptares"), ... and wholly-owned subsidiary of Sosei Group Corporation ("Sosei"; TSE ...
(Date:11/30/2015)... and REHOVOT, Israel , ... specialty pharmaceutical company focused on acquiring and developing innovative ... announced the appointment of Keith A. Katkin ... Gregory J. Flesher , chief executive officer for ... building successful organizations.  As chairman, he will be able ...
Breaking Medicine Technology: